- Home
- WNS vs RXST Comparison
WNS vs RXST Comparison
Compare WNS & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- RXST
- Stock Information
- Founded
- WNS 1996
- RXST 1997
- Country
- WNS India
- RXST United States
- Employees
- WNS N/A
- RXST N/A
- Industry
- WNS Business Services
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WNS Consumer Discretionary
- RXST Health Care
- Exchange
- WNS Nasdaq
- RXST Nasdaq
- Market Cap
- WNS 2.3B
- RXST 2.0B
- IPO Year
- WNS N/A
- RXST 2021
- Fundamental
- Price
- WNS $46.58
- RXST $30.39
- Analyst Decision
- WNS Buy
- RXST Strong Buy
- Analyst Count
- WNS 7
- RXST 8
- Target Price
- WNS $60.43
- RXST $58.13
- AVG Volume (30 Days)
- WNS 432.0K
- RXST 771.0K
- Earning Date
- WNS 01-23-2025
- RXST 02-26-2025
- Dividend Yield
- WNS N/A
- RXST N/A
- EPS Growth
- WNS N/A
- RXST N/A
- EPS
- WNS 2.50
- RXST N/A
- Revenue
- WNS $1,308,696,000.00
- RXST $128,293,000.00
- Revenue This Year
- WNS N/A
- RXST $60.30
- Revenue Next Year
- WNS $7.73
- RXST $33.85
- P/E Ratio
- WNS $18.64
- RXST N/A
- Revenue Growth
- WNS 2.07
- RXST 67.52
- 52 Week Low
- WNS $39.85
- RXST $26.29
- 52 Week High
- WNS $72.57
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- WNS 49.08
- RXST 30.12
- Support Level
- WNS $44.59
- RXST $30.09
- Resistance Level
- WNS $48.12
- RXST $31.92
- Average True Range (ATR)
- WNS 1.40
- RXST 1.86
- MACD
- WNS 0.14
- RXST -0.06
- Stochastic Oscillator
- WNS 70.78
- RXST 37.82
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a Global provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), and South Africa.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.